ATE531376T1 - Verwendung von thioarabinofuranosyl-verbindungen - Google Patents
Verwendung von thioarabinofuranosyl-verbindungenInfo
- Publication number
- ATE531376T1 ATE531376T1 AT99935854T AT99935854T ATE531376T1 AT E531376 T1 ATE531376 T1 AT E531376T1 AT 99935854 T AT99935854 T AT 99935854T AT 99935854 T AT99935854 T AT 99935854T AT E531376 T1 ATE531376 T1 AT E531376T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- compounds
- monoalkylamino
- iid
- haloalkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9386998P | 1998-07-23 | 1998-07-23 | |
| PCT/US1999/016630 WO2000004866A2 (en) | 1998-07-23 | 1999-07-23 | Preparation of thioarabinofuranosyl compounds and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE531376T1 true ATE531376T1 (de) | 2011-11-15 |
Family
ID=22241386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99935854T ATE531376T1 (de) | 1998-07-23 | 1999-07-23 | Verwendung von thioarabinofuranosyl-verbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6576621B1 (de) |
| EP (3) | EP1100512B1 (de) |
| JP (3) | JP4719356B2 (de) |
| AT (1) | ATE531376T1 (de) |
| AU (1) | AU747012B2 (de) |
| CA (1) | CA2338415C (de) |
| ES (3) | ES2402799T3 (de) |
| NZ (1) | NZ509405A (de) |
| WO (1) | WO2000004866A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE531376T1 (de) * | 1998-07-23 | 2011-11-15 | Southern Res Inst | Verwendung von thioarabinofuranosyl-verbindungen |
| EP1541581A1 (de) * | 2002-08-22 | 2005-06-15 | Geneticlab Co., Ltd. | 4-thionukleotid |
| US7524831B2 (en) | 2005-03-02 | 2009-04-28 | Schering Corporation | Treatments for Flaviviridae virus infection |
| MX2009010203A (es) * | 2007-03-23 | 2010-06-01 | Southern Res Inst | Metodo para el tratamiento y prevencion de artritis. |
| AR064165A1 (es) | 2007-12-06 | 2009-03-18 | Richmond Sa Com Ind Y Financie | Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento |
| EP2303226B1 (de) * | 2008-06-25 | 2016-03-23 | Endo Pharmaceuticals Solutions Inc. | Verlängerte freisetzung von exenatid und anderen polypeptiden |
| US20110218170A1 (en) * | 2010-03-02 | 2011-09-08 | Southern Research Institute | Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents |
| PL2832740T3 (pl) | 2012-03-28 | 2019-09-30 | Fujifilm Corporation | Sól 1-(2-deoksy-2-fluoro-4-tio-beta-d-arabinofuranozylo)cytozyny |
| JP6351107B2 (ja) * | 2014-02-18 | 2018-07-04 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| WO2015125781A1 (ja) | 2014-02-18 | 2015-08-27 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| JP6245527B2 (ja) * | 2014-03-24 | 2017-12-13 | 富士フイルム株式会社 | チオラン環もしくはチアン環骨格を有する化合物の製造方法 |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| EP3303361A1 (de) * | 2015-05-27 | 2018-04-11 | Idenix Pharmaceuticals LLC | Nukleotide zur behandlung von krebs |
| WO2017091836A1 (en) * | 2015-11-25 | 2017-06-01 | University Of South Carolina | Enhancement of cytarabine activity by inhibiting cdk8/19 |
| KR102198656B1 (ko) | 2016-08-31 | 2021-01-05 | 후지필름 가부시키가이샤 | 항종양제, 항종양 효과 증강제 및 항종양용 키트 |
| WO2019146130A1 (ja) | 2018-01-29 | 2019-08-01 | 富士フイルム株式会社 | 胆道がん用抗腫瘍剤および胆道がんの処置方法 |
| JP7419259B2 (ja) * | 2018-04-19 | 2024-01-22 | サウザーン リサーチ インスチチュート | 癌の治療のための４’－チオ－ヌクレオチドおよび－ヌクレオシドプロドラッグ |
| JP2022535849A (ja) * | 2019-06-05 | 2022-08-10 | サウザーン リサーチ インスチチュート | チアラビンベースおよびチアラビンのプロドラッグベースの治療 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6401490A (en) * | 1989-09-15 | 1991-04-18 | Southern Research Institute | 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| WO1991008743A1 (en) * | 1989-12-08 | 1991-06-27 | City Of Hope | Circumvention of human tumor drug resistance |
| JPH09249690A (ja) | 1995-07-14 | 1997-09-22 | Yamasa Shoyu Co Ltd | ４’−チオアラビノプリンヌクレオシド |
| JPH0925289A (ja) | 1995-07-14 | 1997-01-28 | Yamasa Shoyu Co Ltd | ４’−チオアラビノピリミジンヌクレオシドの製造方法 |
| JP2943690B2 (ja) | 1996-04-17 | 1999-08-30 | 日本電気株式会社 | セル衝突検出装置 |
| AU749561B2 (en) | 1997-05-09 | 2002-06-27 | Ribozyme Pharmaceuticals, Inc. | Nucleic acid molecules having endonuclease and/or catalytic activity |
| US6548657B1 (en) * | 1997-06-09 | 2003-04-15 | Ribozyme Pharmaceuticals, Inc. | Method for screening nucleic acid catalysts |
| WO1999043690A1 (fr) | 1998-02-25 | 1999-09-02 | Rational Drug Design Laboratories | Compose de l-4'-arabinofuranonucleoside et composition medicinale le contenant |
| ATE531376T1 (de) * | 1998-07-23 | 2011-11-15 | Southern Res Inst | Verwendung von thioarabinofuranosyl-verbindungen |
-
1999
- 1999-07-23 AT AT99935854T patent/ATE531376T1/de active
- 1999-07-23 EP EP99935854A patent/EP1100512B1/de not_active Expired - Lifetime
- 1999-07-23 NZ NZ509405A patent/NZ509405A/en not_active IP Right Cessation
- 1999-07-23 EP EP10179999A patent/EP2332551B1/de not_active Expired - Lifetime
- 1999-07-23 JP JP2000560859A patent/JP4719356B2/ja not_active Expired - Fee Related
- 1999-07-23 EP EP10170453.4A patent/EP2335706B1/de not_active Expired - Lifetime
- 1999-07-23 AU AU51239/99A patent/AU747012B2/en not_active Expired
- 1999-07-23 ES ES10179999T patent/ES2402799T3/es not_active Expired - Lifetime
- 1999-07-23 WO PCT/US1999/016630 patent/WO2000004866A2/en active IP Right Grant
- 1999-07-23 ES ES10170453.4T patent/ES2438144T3/es not_active Expired - Lifetime
- 1999-07-23 CA CA002338415A patent/CA2338415C/en not_active Expired - Lifetime
- 1999-07-23 ES ES99935854T patent/ES2376862T3/es not_active Expired - Lifetime
-
2000
- 2000-01-28 US US09/493,247 patent/US6576621B1/en not_active Expired - Lifetime
-
2003
- 2003-04-07 US US10/407,135 patent/US6870052B2/en not_active Expired - Lifetime
-
2004
- 2004-09-13 US US10/938,542 patent/US7138385B2/en not_active Expired - Lifetime
-
2006
- 2006-08-24 US US11/509,030 patent/US7691820B2/en not_active Expired - Fee Related
-
2010
- 2010-02-23 US US12/710,537 patent/US8178510B2/en not_active Expired - Fee Related
- 2010-04-27 JP JP2010102499A patent/JP2010202655A/ja active Pending
- 2010-10-29 JP JP2010243705A patent/JP5357857B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011032281A (ja) | 2011-02-17 |
| ES2376862T3 (es) | 2012-03-20 |
| CA2338415C (en) | 2006-10-10 |
| EP2332551A1 (de) | 2011-06-15 |
| AU747012B2 (en) | 2002-05-09 |
| US6576621B1 (en) | 2003-06-10 |
| US20030203872A1 (en) | 2003-10-30 |
| US20060287320A1 (en) | 2006-12-21 |
| WO2000004866A3 (en) | 2000-04-20 |
| US6870052B2 (en) | 2005-03-22 |
| EP1100512B1 (de) | 2011-11-02 |
| ES2402799T3 (es) | 2013-05-09 |
| JP4719356B2 (ja) | 2011-07-06 |
| US7691820B2 (en) | 2010-04-06 |
| US8178510B2 (en) | 2012-05-15 |
| US20050038025A1 (en) | 2005-02-17 |
| WO2000004866A9 (en) | 2000-08-10 |
| US7138385B2 (en) | 2006-11-21 |
| AU5123999A (en) | 2000-02-14 |
| EP2335706A1 (de) | 2011-06-22 |
| EP1100512A4 (de) | 2001-10-10 |
| ES2438144T3 (es) | 2014-01-16 |
| JP5357857B2 (ja) | 2013-12-04 |
| JP2010202655A (ja) | 2010-09-16 |
| WO2000004866A2 (en) | 2000-02-03 |
| JP2002521318A (ja) | 2002-07-16 |
| EP1100512A2 (de) | 2001-05-23 |
| NZ509405A (en) | 2004-10-29 |
| US20100216797A1 (en) | 2010-08-26 |
| EP2332551B1 (de) | 2013-01-09 |
| CA2338415A1 (en) | 2000-02-03 |
| EP2335706B1 (de) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE531376T1 (de) | Verwendung von thioarabinofuranosyl-verbindungen | |
| ES2115163T3 (es) | Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis. | |
| ATE149999T1 (de) | Monofluorierte derivate von n-propargyl-1- aminoindan und deren verwendung als monoamino- oxidaseinhibitoren | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| DE68922044D1 (de) | 2,4-Diamino-pyrimidin-3-oxid-Derivate und deren Verwendung bei der Behandlung und zur Verhütung von Haarfall. | |
| GB9801690D0 (en) | Therapeutic agents | |
| ES2187473T3 (es) | Triarylimidazoles. | |
| TR199901653T2 (xx) | Fitalazinonlar. | |
| PT83961A (de) | Pyrazolin-derivate ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung | |
| NO305174B1 (no) | Heterocykliske forbindelser | |
| DK337589D0 (da) | 3r,s- og 3r-formerne af 3-substuerede 1-(2-aryl -eller heteroarylethyl)piperidin-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af sygdommme forbundet med aendret motilitet og/eller tonus af glatmuskel samt farmaceutiske praeparater indeholdende disse forbindelser | |
| FR2705962B1 (fr) | Arylpyrazoles fongicides. | |
| DK397988A (da) | Dihydropyridinforbindelser og deres avendelse til fremstilling af et laegemiddel til behandling af alergiske og inflammatoriske tilstande samt farmaceutiske praeparater indeholdende forbindelserne | |
| DE3668171D1 (de) | 1-aryl-5-alkoximinoalkylamino-pyrazole. | |
| DE69609812D1 (de) | Substituierte phenylverbindungen als endothelinantagoniste | |
| TR199902115T2 (xx) | 2,3- Dihidrofuro (3,2-b) piridiun t�revleri, haz�rlan��lar� ve terapide uygulanmalar�. | |
| NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
| NO972943D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
| DE69909811D1 (de) | Substituierte isoxazolylthiophenverbindungen | |
| TR200001941T1 (tr) | TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri. | |
| ATE218138T1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
| EP0785193A4 (de) | Arylthiadiazol-derivate und diese enthaltende antivirale arzneimittel | |
| TR199801683A2 (xx) | Yeni �re t�revleri. | |
| TW348053B (en) | Herbicidal mixtures for paddy fields | |
| ES2192342T3 (es) | 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa. |